Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2)

Update Il y a 5 ans
Reference: NCT00886353

Woman and Man

Extract

The purpose of this study is to define the dose for a Phase II study and to investigate safety and tolerability of intravenous administration of recombinant soluble human Angiotensin Converting Enzyme 2 in healthy volunteers.


Inclusion criteria

  • Pulmonary diseases ,Cardiovascular Diseases ,Kidney Diseases ,Cancer Diseases

Links